中医药治疗糖尿病肾病研究进展  被引量:5

Research Progress of Traditional Chinese Medicine in the Treatment of Diabetic Nephropathy

在线阅读下载全文

作  者:杨敏 李瑾 YANG Min;LI Jin(The First Clinical Medical College,Shandong University of Chinese Medicine,Shandong Province,Jinan 250355,China)

机构地区:[1]山东中医药大学第一临床医学院,山东济南250355

出  处:《中国中医药现代远程教育》2023年第23期86-89,共4页Chinese Medicine Modern Distance Education of China

摘  要:糖尿病肾病是糖尿病患者最常见的微血管并发症之一,早期可无任何不适症状,容易被漏诊误治,患者发现病情时常常已进入糖尿病肾病Ⅳ期甚至终末期。目前西医尚无针对糖尿病肾病的特异性治疗,对糖尿病肾病的早期控制有困难。中医学根据临床辨证,结合历史文献,将糖尿病肾病归为“消渴肾病”的范畴,在治疗上主张“未病先防,既病防变”,通过调节机体的偏盛偏衰,治疗糖尿病肾病,取得了良好的临床效果。并且在患者确诊糖尿病肾病后,联合使用中医学与现代医学,能显著加强治疗效果,干预实质性肾脏病理改变,延缓糖尿病肾病的进展。Diabetic nephropathy is one of the most common microvascular complications in diabetic patients,and there may be no symptoms of self-conscious discomfort in the early stage,which is easy to miss diagnosis and mistreatment,and when the disease is found,it has often entered stage Ⅳ or even end-stage renal disease of diabetic nephropathy.At present,western medicine has not yet specific treatment for diabetic nephropathy,which is difficult to control early diabetic nephropathy.According to the clinical syndrome differentiation combined with historical literature,Chinese medicine classifies diabetic nephropathy into the category of“consumptive thirst nephropathy”,it advocates“prevention before illness,prevention of disease”,and achieves good clinical efficacy by regulating the body’s partial prosperity and decline,treating diabetic nephropathy,and can be used in combination with modern medicine after the diagnosis of diabetic nephropathy,significantly strengthening the therapeutic effect,and giving intervention before substantial renal pathological changes occur in patients with diabetic nephropathy to delay the progression of diabetic nephropathy.

关 键 词:消渴肾病 糖尿病肾病 治未病 中医药疗法 综述 

分 类 号:R259[医药卫生—中西医结合] R277.5[医药卫生—中医内科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象